ArticleEBioMedicine2025
Closing the AI generalisation gap by adjusting for dermatology condition distribution differences across clinical settings.
Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Consumer Understanding of Skin Concerns With an AI-Powered Informational Tool.JAMA dermatology · 2026Trial
- Artificial intelligence in dermatology: A literature review of current evidence and clinical implementation.JID innovations : skin science from molecules to population health · 2026Review
- Demographic Reporting and the Absence of Hispanic/Latino Representation in Dermatology Artificial Intelligence: A Scoping Review.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026Article
- DermNet: integrative CNN-ViT architecture for bias mitigation in dermatological diagnostics using advanced unsupervised lesion segmentation.Scientific reports · 2026Article
- Responsible Innovation in AI-Driven Teledentistry: Ethical, Legal, and Economic Considerations for the Globalization Era.Discoveries (Craiova, Romania)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGeneralisation of artificial intelligence (AI) models to a new setting is challenging. In this study, we seek to understand the robustness of a dermatology (AI) model and whether it generalises from telemedicine cases to a new setting including both patient-submitted photographs ("PAT") and clinician-taken photographs in-clinic ("CLIN").
methodsA retrospective cohort study involving 2500 cases previously unseen by the AI model, including both PAT and CLIN cases, from 22 clinics in the San Francisco Bay Area, spanning November 2015 to January 2021. The primary outcome measure for the AI model and dermatologists was the top-3 accuracy, defined as whether their top 3 differential diagnoses contained the top reference diagnosis from a panel of dermatologists per case.
findingsThe AI performed similarly between PAT and CLIN images (74% top-3 accuracy in CLIN vs. 71% in PAT), however, dermatologists were more accurate in PAT images (79% in CLIN vs. 87% in PAT). We demonstrate that demographic factors were not associated with AI or dermatologist errors; instead several categories of conditions were associated with AI model errors (p < 0.05). Resampling CLIN and PAT to match skin condition distributions to the AI development dataset reduced the observed differences (AI: 84% CLIN vs. 79% PAT; dermatologists: 77% CLIN vs. 89% PAT). We demonstrate a series of steps to close the generalisation gap, requiring progressively more information about the new dataset, ranging from the condition distribution to additional training data for rarer conditions. When using additional training data and testing on the dataset without resampling to match AI development, we observed comparable performance from end-to-end AI model fine tuning (85% in CLIN vs. 83% in PAT) vs. fine tuning solely the classification layer on top of a frozen embedding model (86% in CLIN vs. 84% in PAT).
interpretationAI algorithms can be efficiently adapted to new settings without additional training data by recalibrating the existing model, or with targeted data acquisition for rarer conditions and retraining just the final layer.
fundingGoogle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.